Speakers | Kisaco Research

Speakers

Animal Health, Nutrition & Technology Innovation USA 2024
June 2024
Boston, MA
  • Author:

    Stephen Lesser

    Principal
    Novaquest Capital Management

    Stephen Lesser

    Principal
    Novaquest Capital Management
  • Author:

    Mareese Keane

    Co-Founder
    Opengate Partners

    Mareese Keane

    Co-Founder
    Opengate Partners
  • Author:

    Susan Groeneveld

    Founder
    sylvester.ai

    Susan Groeneveld

    Founder
    sylvester.ai
  • Author:

    Cherylyn Harley LeBon

    Partner
    Womble Bond Dickinson

    Cherylyn Harley LeBon

    Partner
    Womble Bond Dickinson
  • Author:

    Rob Hunter

    CEO/CSRO/CSO
    One Medicine Consulting/ VHRC / Sorensis

    Rob Hunter

    CEO/CSRO/CSO
    One Medicine Consulting/ VHRC / Sorensis
  • Author:

    Richard Kestenbaum

    Partner
    Triangle Capital, LLC

    Richard is a co-founder and Partner of Triangle Capital and has been an investment banker for over 35 years. Richard has a great deal of experience advising clients in merchandising businesses, particularly in the Retail & Consumer sector. Richard is an often-quoted expert on the retail and merchandising industries. He is a Contributor to Forbes.com where he writes a regular blog about trends in retail and consumer product businesses. He also appears regularly in print and other media as well as industry panels and speaking programs.

    Before co-founding Triangle, Richard was a Managing Director at a boutique investment banking firm called Financo, Inc. While at Financo, Richard was responsible for a majority of the firm’s apparel industry transactions. Prior to joining Financo, Richard was a Partner and First Vice President at Drexel Burnham Lambert Inc. At Drexel, Richard was responsible for a group of 14 professionals doing middle-market mergers and acquisitions around the world.

    Richard is the co-author of three books on finance and computer programming. He is formerly an Adjunct Assistant Professor of International Business at the graduate program of the Stern School of Business at York University.

    Richard received a BS in Accounting from New York University and an MBA with a concentration in Finance from Harvard University. Richard is married and lives in New York.

    Click here to read Richard’s blog and follow him on Forbes.com.

    Richard Kestenbaum

    Partner
    Triangle Capital, LLC

    Richard is a co-founder and Partner of Triangle Capital and has been an investment banker for over 35 years. Richard has a great deal of experience advising clients in merchandising businesses, particularly in the Retail & Consumer sector. Richard is an often-quoted expert on the retail and merchandising industries. He is a Contributor to Forbes.com where he writes a regular blog about trends in retail and consumer product businesses. He also appears regularly in print and other media as well as industry panels and speaking programs.

    Before co-founding Triangle, Richard was a Managing Director at a boutique investment banking firm called Financo, Inc. While at Financo, Richard was responsible for a majority of the firm’s apparel industry transactions. Prior to joining Financo, Richard was a Partner and First Vice President at Drexel Burnham Lambert Inc. At Drexel, Richard was responsible for a group of 14 professionals doing middle-market mergers and acquisitions around the world.

    Richard is the co-author of three books on finance and computer programming. He is formerly an Adjunct Assistant Professor of International Business at the graduate program of the Stern School of Business at York University.

    Richard received a BS in Accounting from New York University and an MBA with a concentration in Finance from Harvard University. Richard is married and lives in New York.

    Click here to read Richard’s blog and follow him on Forbes.com.

  • Author:

    Bruce Truman

    President and Founder
    BLT Technology & Innovation Group

    Bruce Truman

    President and Founder
    BLT Technology & Innovation Group
  • Author:

    Neal Fishman

    Distinguished Engineer and CTO of Data-Based Pathology
    IBM

    Neal Fishman

    Distinguished Engineer and CTO of Data-Based Pathology
    IBM
  • Author:

    Aaron Schacht

    CEO
    BIomEdit

    Prior to this role, Mr. Aaron Schacht was the Vice President of Global Research and Development / Regulatory Affairs at Elanco Animal Healthheld. Before that, he held the role of Global Brand Development Leader – Pain in Lilly Biomedicines. He was the global leader for product development and commercialization activities for LY2951742 – Lilly’s novel CGRP neutralizing antibody – a new potential treatment for prevention of Migraine and Cluster Headache. In 2012, Schacht joined Lilly Biomedicines as Senior Advisor – Strategy & Business Development for Lilly BioMedicines. His responsibilities included oversight of Therapeutic Strategy development, R&D Portfolio Management, and Business Development for Lilly BioMedicines – Lilly’s largest business unit. Past roles included serving as Executive Director, Global External R&D, at Eli Lilly and Company, where he was responsible for implementation of strategies which aim to leverage novel approaches to external partnerships to augment Lilly’s access to pharmaceutical innovation as well as Executive Director of LRL (Lilly Research Labs) Strategy, Portfolio Management and Project Management where he was responsible for strategic planning, R&D portfolio and project management. Prior to these roles, he was Director, Innovation Center in the eLilly organization where he focused on the exploration, incubation and implementation of new business models and capabilities relevant to the strategic evolution of the pharmaceutical industry. In 2002, during a short leave from Lilly, Mr. Schacht was co-founder, President and CEO of Artesian Therapeutics, a Gaithersburg, MD cardiovascular drug discovery start-up. Mr. Schacht began his career at Lilly in 1990 as a medicinal chemist, and spent 5 years in the laboratory working to discover pharmaceuticals to treat cardiovascular disorders. Schacht studied Organic chemistry at the University of Illinois, receiving his Bachelors of Science degree in 1990.

    Aaron Schacht

    CEO
    BIomEdit

    Prior to this role, Mr. Aaron Schacht was the Vice President of Global Research and Development / Regulatory Affairs at Elanco Animal Healthheld. Before that, he held the role of Global Brand Development Leader – Pain in Lilly Biomedicines. He was the global leader for product development and commercialization activities for LY2951742 – Lilly’s novel CGRP neutralizing antibody – a new potential treatment for prevention of Migraine and Cluster Headache. In 2012, Schacht joined Lilly Biomedicines as Senior Advisor – Strategy & Business Development for Lilly BioMedicines. His responsibilities included oversight of Therapeutic Strategy development, R&D Portfolio Management, and Business Development for Lilly BioMedicines – Lilly’s largest business unit. Past roles included serving as Executive Director, Global External R&D, at Eli Lilly and Company, where he was responsible for implementation of strategies which aim to leverage novel approaches to external partnerships to augment Lilly’s access to pharmaceutical innovation as well as Executive Director of LRL (Lilly Research Labs) Strategy, Portfolio Management and Project Management where he was responsible for strategic planning, R&D portfolio and project management. Prior to these roles, he was Director, Innovation Center in the eLilly organization where he focused on the exploration, incubation and implementation of new business models and capabilities relevant to the strategic evolution of the pharmaceutical industry. In 2002, during a short leave from Lilly, Mr. Schacht was co-founder, President and CEO of Artesian Therapeutics, a Gaithersburg, MD cardiovascular drug discovery start-up. Mr. Schacht began his career at Lilly in 1990 as a medicinal chemist, and spent 5 years in the laboratory working to discover pharmaceuticals to treat cardiovascular disorders. Schacht studied Organic chemistry at the University of Illinois, receiving his Bachelors of Science degree in 1990.

  • Author:

    Theo Weening

    Partner
    The Sustainable Meats Group

    Theo Weening

    Partner
    The Sustainable Meats Group
  • Author:

    Candise Goodwin

    Founder
    Outlier Advisors

    Candise Goodwin

    Founder
    Outlier Advisors
  • Author:

    Paula Bamford

    VP, Veterinary Services
    Petco

    Paula Bamford

    VP, Veterinary Services
    Petco
  • Author:

    Emily Aston, DVM, PhD

    Senior Program Manager, Animal Health & Nutrition
    TechAccel LLC

    Emily Aston, DVM, PhD

    Senior Program Manager, Animal Health & Nutrition
    TechAccel LLC
  • Author:

    Brett Wong

    Principle
    Anterra Capital

    Brett Wong

    Principle
    Anterra Capital
  • Author:

    Lashonda Geffrard

    Founder
    Black Pet Business Network

    Lashonda Geffrard's name is synonymous with passion, dedication, and innovation. As the driving force behind Black Pet Business Network, The Paw Shop, and Paws of Hope Florida. Lashonda is a force to be reckoned with, a true trailblazer in the world of entrepreneurship, and animal welfare. Her boundless love for animals and her drive to create a more inclusive and thriving pet industry has catapulted her into the realm of expert pet industry speaking and influence.

     

    With an unwavering commitment to positively impacting the pet industry as a whole, Beyond her speaking engagements, Lashonda's impact on the pet industry extends to her role as a popular columnist for various industry publications. Her thought-provoking articles delve into the depths of the industry and shed light on emerging trends.

    Lashonda Geffrard

    Founder
    Black Pet Business Network

    Lashonda Geffrard's name is synonymous with passion, dedication, and innovation. As the driving force behind Black Pet Business Network, The Paw Shop, and Paws of Hope Florida. Lashonda is a force to be reckoned with, a true trailblazer in the world of entrepreneurship, and animal welfare. Her boundless love for animals and her drive to create a more inclusive and thriving pet industry has catapulted her into the realm of expert pet industry speaking and influence.

     

    With an unwavering commitment to positively impacting the pet industry as a whole, Beyond her speaking engagements, Lashonda's impact on the pet industry extends to her role as a popular columnist for various industry publications. Her thought-provoking articles delve into the depths of the industry and shed light on emerging trends.

  • Author:

    Eric Buda

    Sr Corporate Partnership Manager
    Plug and Play Tech Center

    Eric Buda

    Sr Corporate Partnership Manager
    Plug and Play Tech Center
  • Author:

    Christopher Oliviero

    General Manager
    Niman Ranch

    Christopher Oliviero

    General Manager
    Niman Ranch
  • Author:

    Linda Rhodes

    VMD, PhD, Independent and ex-CSO
    Independent Animal Health

    Dr. Rhodes has 28 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.

    Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has 28 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine. She has an extensive background in physiology, veterinary medicine, and molecular biology. As a senior research fellow at Merck Research Laboratories for 10 years, she led pre-clinical biology evaluation of several marketed human drugs. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. She worked for Merial Ltd. as director of development projects, leading project teams developing novel compounds for a variety of indications and headed new technology assessment, leading the evaluation of licensing opportunities. In April 2001, she formed AlcheraBio, a consulting, marketing, communications and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies, with clients in the US, European Union, Canada and Australia. AlcheraBio was acquired in 2008 by Argenta, and in 2011, Dr. Rhodes accepted a position as CEO of Aratana Therapeutics, a company developing innovative new medicines for dogs and cats, and subsequently, when the company became public (PETX) served as its Chief Scientific Officer. During her tenure, development was completed on three new pet therapeutics: two new molecules with novel mechanisms of actions were approved by the FDA, and a third drug had FDA registration completed and was approved in August, 2016. She is currently retired and an independent consultant. She is a member of the Board of Directors of ImmuCell (NASDAQ: ICCC) and the Alliance for Contraception in Dogs and Cats, serves on the Scientific Advisory Board of the Found Animals Foundation. She is an adjunct faculty member in the Graduate Animal Science program at Rutgers University.

    Linda Rhodes

    VMD, PhD, Independent and ex-CSO
    Independent Animal Health

    Dr. Rhodes has 28 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.

    Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has 28 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine. She has an extensive background in physiology, veterinary medicine, and molecular biology. As a senior research fellow at Merck Research Laboratories for 10 years, she led pre-clinical biology evaluation of several marketed human drugs. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. She worked for Merial Ltd. as director of development projects, leading project teams developing novel compounds for a variety of indications and headed new technology assessment, leading the evaluation of licensing opportunities. In April 2001, she formed AlcheraBio, a consulting, marketing, communications and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies, with clients in the US, European Union, Canada and Australia. AlcheraBio was acquired in 2008 by Argenta, and in 2011, Dr. Rhodes accepted a position as CEO of Aratana Therapeutics, a company developing innovative new medicines for dogs and cats, and subsequently, when the company became public (PETX) served as its Chief Scientific Officer. During her tenure, development was completed on three new pet therapeutics: two new molecules with novel mechanisms of actions were approved by the FDA, and a third drug had FDA registration completed and was approved in August, 2016. She is currently retired and an independent consultant. She is a member of the Board of Directors of ImmuCell (NASDAQ: ICCC) and the Alliance for Contraception in Dogs and Cats, serves on the Scientific Advisory Board of the Found Animals Foundation. She is an adjunct faculty member in the Graduate Animal Science program at Rutgers University.

  • Author:

    Mike Charles

    Owner
    LaBelle Patrimoine Heritage Chickens

    Mike Charles

    Owner
    LaBelle Patrimoine Heritage Chickens
  • Author:

    Victoria Mo

    Co-Founder
    Ten Lives

    Victoria Mo

    Co-Founder
    Ten Lives
  • Author:

    Julia Loew

    Senior Vice President, Commercial Operations
    MWI Animal Health

    Julia Loew

    Senior Vice President, Commercial Operations
    MWI Animal Health
  • Author:

    Sanjeev Anand

    Vice President
    TechAccel

    Sanjeev Anand

    Vice President
    TechAccel
  • Author:

    Grant Barnekow

    Founder
    Sphinx

    Grant Barnekow

    Founder
    Sphinx
  • Author:

    Judy Schnurr

    Director, Nutrition Innovation
    Hills Pet Nutrition

    Judy's career has spanned nutritional innovation, beginning with a PhD in plant molecular biology, biochemistry, and genetics

    -she has worked for various companies across plant, microbial, and animal nutrition research

    -joined Hill's Pet Nutrition 2 y ago and leads a team focused on innovation in the pet and pet microbiome space

    Judy Schnurr

    Director, Nutrition Innovation
    Hills Pet Nutrition

    Judy's career has spanned nutritional innovation, beginning with a PhD in plant molecular biology, biochemistry, and genetics

    -she has worked for various companies across plant, microbial, and animal nutrition research

    -joined Hill's Pet Nutrition 2 y ago and leads a team focused on innovation in the pet and pet microbiome space

  • Author:

    Tom Overbay

    Partner
    Expedite Animal Health

    Tom Overbay

    Partner
    Expedite Animal Health
  • Author:

    Natalie Marks

    Executive Committee
    VANE

    Natalie Marks

    Executive Committee
    VANE
  • Author:

    Luis Lopez

    Sr. Leader Healthcare
    Amazon Business

    Luis Lopez

    Sr. Leader Healthcare
    Amazon Business
  • Author:

    Audrey Wystrach DVM

    Founder and Chief Executive Officer
    Petfolk

    Audrey Wystrach DVM

    Founder and Chief Executive Officer
    Petfolk
  • Author:

    Miriam Martin

    Director of Animal Health and Welfare
    North American Meat Institute

    Miriam Martin

    Director of Animal Health and Welfare
    North American Meat Institute
  • Author:

    Ira Gordon

    Co-Founder
    VANE

    Ira Gordon

    Co-Founder
    VANE
  • Author:

    Dr. Haley Larson

    Assistant Professor of Animal Health
    Kansas State University

    Dr. Haley Larson

    Assistant Professor of Animal Health
    Kansas State University
  • Author:

    Andrea Nance

    Global Head of Corporate Sustainability
    Zoetis

    Andrea Nance

    Global Head of Corporate Sustainability
    Zoetis
  • Author:

    Heather Fowler

    Director, Producer and Public Health
    National Pork Board

    Heather Fowler

    Director, Producer and Public Health
    National Pork Board
  • Author:

    David Haworth

    President
    Vidium Animal Health

    David Haworth

    President
    Vidium Animal Health
  • Author:

    Bob Lester

    Chief Medical Officer
    WellHaven Pet Health

    Bob Lester

    Chief Medical Officer
    WellHaven Pet Health
  • Author:

    Ginny Siller

    Director Government Affairs
    Animal Health Institute

    Ginny Siller

    Director Government Affairs
    Animal Health Institute
  • Author:

    Alejandro Bernal

    President & CEO
    PetDx

    Alejandro Bernal

    President & CEO
    PetDx
  • Author:

    Mark Krivis

    Senior Director, Business Development Lead
    Zoetis

    Mark Krivis

    Senior Director, Business Development Lead
    Zoetis
  • Author:

    Deborah Dullen

    President and CEO
    BioTraceIT

    Deborah Dullen

    President and CEO
    BioTraceIT
  • Author:

    Richard Nilsson

    CEO and Founder
    MyPetGo

    Richard Nilsson

    CEO and Founder
    MyPetGo
  • Author:

    Brendan Lynch

    SVP, Urgent Care Hospitals and Innovation
    VCA Animal Hospitals

    Brendan Lynch

    SVP, Urgent Care Hospitals and Innovation
    VCA Animal Hospitals
  • Author:

    Megan Grether

    Head of Global Business Development and Licensing Animal Health
    Boehringer Ingelheim

    Megan Grether

    Head of Global Business Development and Licensing Animal Health
    Boehringer Ingelheim
  • Author:

    Joe Kennedy

    Managing Director
    Skills Alliance

    Joe Kennedy

    Managing Director
    Skills Alliance
  • Author:

    Lucas Huntimer

    Senior Advisor External Innovation
    Elanco

    Lucas Huntimer

    Senior Advisor External Innovation
    Elanco
  • Author:

    Scott Brown

    Senior Executive Director
    Cherry Tree & Associates

    Scott Brown

    Senior Executive Director
    Cherry Tree & Associates
  • Author:

    Chuck Latham

    CEO
    H&C Animal Health

    Chuck Latham

    CEO
    H&C Animal Health
  • Author:

    Cindy Trice

    Founder and CEO
    Relief Rover

    Cindy Trice

    Founder and CEO
    Relief Rover
  • Author:

    Sheri Gilmartin

    Vice President, Data Services
    Vetsource

    Sheri Gilmartin

    Vice President, Data Services
    Vetsource
  • Author:

    Brian Kanke

    President
    Zoo Pharma Dynamics

    Brian Kanke

    President
    Zoo Pharma Dynamics

Other events you might be interested in:

Animal Health LatAm 2023

Animal Health, Nutrition and Technology Innovation Asia 2023

Animal Health, Nutrition and Technology Innovation Europe 2022